As of Oct 4, 2026
Stockyard is a $7–$30/month platform that automates your own investing rules. Here's how it compares to the platforms serious investors already use.
Most investing platforms hand you excellent data and expect you to keep checking it. Stockyard is built around a different division of labor: you state your strategy as rules, and the platform watches the market for you.
If you are weighing Stockyard against a platform you already use, start here. Every comparison below is written to be fair - each one concedes what the other platform does better before it says anything about us. And every comparison starts from the same table, with the same Stockyard claims, adding rows only where the other platform is strong. A fixed yardstick, applied to us first.
Automation - Smartfolios. A Smartfolio is your strategy as standing instructions: fundamental tests stated as percentile rankings, sectors chosen by revenue contribution, a technical trigger that fires buys, and sell rules decided in advance. Stockyard backtests the rules on point-in-time data, then runs them daily against 5,000+ stocks - every earnings report as it lands, every price move - and alerts you when a stock qualifies or a sell rule fires. It watches, so you don't have to.
Syd, the AI research assistant. Syd explains any stock's numbers in plain English and can build a Smartfolio or a search from a plain-English description. The numbers underneath are calculated first, deterministically. AI where it helps - language. Rules where it matters - decisions.
Ease of use. No formula language to learn, no family of products to stack, no ads. One product, three tiers. Ease of use can't really be argued; it's only experienced - so Stockyard is 30 days of full Pro access, then the tier you choose.
IBD offers the CAN SLIM method, house ratings, curated lists, and MarketSurge's chart-pattern recognition, but you do the checking yourself, every day. This comparison puts Stockyard's automated strategies next to IBD's ratings, lists, and product family.
Portfolio123 supports ranking systems from factors and formulae, and you backtest on point-in-time data. This comparison puts Stockyard’s automated strategies next to the Portfolio123 quantitative workbench.
IBD, MarketSurge and CAN SLIM are trademarks of Investor's Business Daily, LLC.
Portfolio123 is a trademark of Prism Research, Inc (DBA Portfolio123).
Start free at stockyardinvest.com - full access for 30 days, no credit card required.